Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1988 Jul;26(7):1253–1256. doi: 10.1128/jcm.26.7.1253-1256.1988

Susceptibility testing of anaerobic bacteria.

S M Finegold 1
PMCID: PMC266587  PMID: 3045147

Full text

PDF
1253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett J. G., Sutter V. L., Finegold S. M. Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med. 1972 Nov 16;287(20):1006–1010. doi: 10.1056/NEJM197211162872002. [DOI] [PubMed] [Google Scholar]
  2. Bawdon R. E., Crane L. R., Palchaudhuri S. Antibiotic resistance in anaerobic bacteria: molecular biology and clinical aspects. Rev Infect Dis. 1982 Nov-Dec;4(6):1075–1095. doi: 10.1093/clinids/4.6.1075. [DOI] [PubMed] [Google Scholar]
  3. Bryan C. S., Reynolds K. L., Kirkhart B., Brown J. J. Bacteroides bacteremia. Analysis of 142 episodes from one metropolitan area. Arch Surg. 1984 Aug;119(8):894–898. doi: 10.1001/archsurg.1984.01390200014003. [DOI] [PubMed] [Google Scholar]
  4. Chow A. W., Guze L. B. Bacteroidaceae bacteremia: clinical experience with 112 patients. Medicine (Baltimore) 1974 Mar;53(2):93–126. [PubMed] [Google Scholar]
  5. Cuchural G. J., Jr, Tally F. P., Jacobus N. V., Gorbach S. L., Aldridge K., Cleary T., Finegold S. M., Hill G., Iannini P., O'Keefe J. P. Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother. 1984 Aug;26(2):145–148. doi: 10.1128/aac.26.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cuchural G., Tally F. P. Factors affecting the choice of antimicrobial therapy for anaerobic infection. J Antimicrob Chemother. 1982 Aug;10 (Suppl A):11–22. doi: 10.1093/jac/10.suppl_a.11. [DOI] [PubMed] [Google Scholar]
  7. Gemmell C. G., Peterson P. K., Schmeling D., Mathews J., Quie P. G. Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes. Eur J Clin Microbiol. 1983 Aug;2(4):327–334. doi: 10.1007/BF02019462. [DOI] [PubMed] [Google Scholar]
  8. George W. L., Kirby B. D., Sutter V. L., Wheeler L. A., Mulligan M. E., Finegold S. M. Intravenous metronidazole for treatment of infections involving anaerobic bacteria. Antimicrob Agents Chemother. 1982 Mar;21(3):441–449. doi: 10.1128/aac.21.3.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goldstein E. J., Lewis R. P., Sutter V. L., Finegold S. M. Erythromycin for anaerobic pleuropulmonary and soft-tissue infections. JAMA. 1979 Aug 3;242(5):435–438. [PubMed] [Google Scholar]
  10. Heseltine P. N., Appleman M. D., Leedom J. M. Epidemiology and susceptibility of resistant Bacteroides fragilis group organisms to new beta-lactam antibiotics. Rev Infect Dis. 1984 Mar-Apr;6 (Suppl 1):S254–S259. doi: 10.1093/clinids/6.supplement_1.s254. [DOI] [PubMed] [Google Scholar]
  11. Heseltine P. N., Busch D. F., Meyer R. D., Finegold S. M. Cefoxitin: clinical evaluation in thirty-eight patients. Antimicrob Agents Chemother. 1977 Mar;11(3):427–434. doi: 10.1128/aac.11.3.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johnson C. C., Reinhardt J. F., Edelstein M. A., Mulligan M. E., George W. L., Finegold S. M. Bacteroides gracilis, an important anaerobic bacterial pathogen. J Clin Microbiol. 1985 Nov;22(5):799–802. doi: 10.1128/jcm.22.5.799-802.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kirby B. D., Busch D. F., Citron D. M., Finegold S. M. Cefoxitin for treatment of infections due to anaerobic bacteria. Rev Infect Dis. 1979 Jan-Feb;1(1):113–117. doi: 10.1093/clinids/1.1.113. [DOI] [PubMed] [Google Scholar]
  14. Klein R. A., Busch D. F., Wilson S. E., Flora D. J., Finegold S. M. Doxycycline in abdominal surgery. JAMA. 1977 Oct 31;238(18):1933–1935. [PubMed] [Google Scholar]
  15. Mathias R. G., Harding G. K., Gurwith M. J., Stiver H. G., Sigurdson E., Gratton C. A., Ronald A. R. Bacteremia due to Bacteroidacceae: a review of 92 cases. J Infect Dis. 1977 Mar;135 (Suppl):S69–S73. doi: 10.1093/infdis/135.supplement.s69. [DOI] [PubMed] [Google Scholar]
  16. Nobles E. R., Jr Bacteroides infections. Ann Surg. 1973 May;177(5):601–606. [PMC free article] [PubMed] [Google Scholar]
  17. Nord C. E., Olsson-Liljequist B. Anaerobic bacteria and beta-lactam antibiotics. Scand J Infect Dis Suppl. 1984;42:72–82. [PubMed] [Google Scholar]
  18. Piddock L. J., Wise R. Newer mechanisms of resistance to beta-lactam antibiotics in gram-negative bacteria. J Antimicrob Chemother. 1985 Sep;16(3):279–284. doi: 10.1093/jac/16.3.279. [DOI] [PubMed] [Google Scholar]
  19. Polk B. F., Kasper D. L. Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med. 1977 May;86(5):569–571. doi: 10.7326/0003-4819-86-5-569. [DOI] [PubMed] [Google Scholar]
  20. Tally F. P. Factors affecting antimicrobial agents in an anaerobic abscess. J Antimicrob Chemother. 1978 Jul;4(4):299–302. doi: 10.1093/jac/4.4.299. [DOI] [PubMed] [Google Scholar]
  21. Wexler H. M., Finegold S. M. Antimicrobial resistance in Bacteroides. J Antimicrob Chemother. 1987 Feb;19(2):143–146. doi: 10.1093/jac/19.2.143. [DOI] [PubMed] [Google Scholar]
  22. Yee M. H., Guiney D. G., Hasegawa P., Davis C. E. The clinical significance of clindamycin-resistant Bacteroides fragilis. JAMA. 1982 Oct 15;248(15):1860–1861. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES